Zobrazeno 1 - 10
of 239
pro vyhledávání: '"Nian XIONG"'
Autor:
Yiming Wang, Yun Xia, Liang Kou, Sijia Yin, Xiaosa Chi, Jingwen Li, Yadi Sun, Jiawei Wu, Qiulu Zhou, Wenkai Zou, Zongjie Jin, Jinsha Huang, Nian Xiong, Tao Wang
Publikováno v:
Neurobiology of Disease, Vol 184, Iss , Pp 106224- (2023)
Parkinson's disease (PD) is currently the fastest growing disabling neurological disorder worldwide, with motor and non-motor symptoms being its main clinical manifestations. The primary pathological features include a reduction in the number of dopa
Externí odkaz:
https://doaj.org/article/0be2dfa2c79542be8a8d0e8ec54b6154
Autor:
Xinyu Hu, Kexin Guo, Jingwen Li, Xinyi Wang, Hanshu Liu, Qinwei Yu, Guiying Kuang, Gang Li, Jinsha Huang, Hongge Li, Zhicheng Lin, Nian Xiong
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
Hemifacial spasm (HFS) is a rare movement disorder characterized by involuntary muscle contractions on one side of the face. Compared to the high therapeutic effect, adverse effects of botulinum toxin treatment for HFS occurred rarely. However, manag
Externí odkaz:
https://doaj.org/article/650e142d502e467ba857f7e526996087
Autor:
Jingya Zhao, Jinnong Zhang, Yang Jin, Zhouping Tang, Ke Hu, Hui Sun, Mengmeng Shi, Qingyuan Yang, Peiyu Gu, Hongrong Guo, Qi Li, Haiying Zhang, Chenghong Li, Ming Yang, Nian Xiong, Xuan Dong, Juanjuan Xu, Fan Lin, Tao Wang, Chao Yang, Bo Huang, Jingyi Zhang, Shi Chen, Qiong He, Min Zhou, Jieming Qu, Peifang Wei
Publikováno v:
Chinese Medical Journal, Vol 135, Iss 13, Pp 1531-1538 (2022)
Abstract. Background:. To date, there is no effective medicine to treat coronavirus disease 2019 (COVID-19), and the antiviral efficacy of arbidol in the treatment for COVID-19 remained equivocal and controversial. The purpose of this study was to ev
Externí odkaz:
https://doaj.org/article/f7f6211ddd43418c9e32045c48b28ffb
Autor:
Jingwen Li, Hanshu Liu, Xinyi Wang, Yun Xia, Jinsha Huang, Tao Wang, Zhicheng Lin, Nian Xiong
Publikováno v:
npj Parkinson's Disease, Vol 8, Iss 1, Pp 1-12 (2022)
Abstract An important pathophysiological component of Parkinson’s Disease (PD) is circadian rhythm disorder, closely related to a decrease in circulated melatonin (MLT) level. It has been reported recently that retinoic acid-associated orphan nucle
Externí odkaz:
https://doaj.org/article/fd5d7b51f68b4bb0b8938b8dd44ab552
Autor:
Liang Kou, Xiaosa Chi, Yadi Sun, Chao Han, Fang Wan, Junjie Hu, Sijia Yin, Jiawei Wu, Yunna Li, Qiulu Zhou, Wenkai Zou, Nian Xiong, Jinsha Huang, Yun Xia, Tao Wang
Publikováno v:
Journal of Neuroinflammation, Vol 19, Iss 1, Pp 1-20 (2022)
Abstract Background Circadian disturbance is a common nonmotor complaint in Parkinson’s disease (PD). The molecular basis underlying circadian rhythm in PD is poorly understood. Neuroinflammation has been identified as a key contributor to PD patho
Externí odkaz:
https://doaj.org/article/0d3c0a38e4914f6b836f6675fe572282
Publikováno v:
Alzheimer’s Research & Therapy, Vol 13, Iss 1, Pp 1-5 (2021)
Abstract Challenges have been recognized in healthcare of patients with Alzheimer’s disease (AD) in the COVID-19 pandemic, given a high infection and mortality rate of COVID-19 in these patients. This situation urges the identification of underlyin
Externí odkaz:
https://doaj.org/article/81eb0639729744809973fea92d24a317
Autor:
Hui Li, Nian Xiong, Changjun Li, Yanhong Gong, Li Liu, Heping Yang, Xiangping Tan, Nan Jiang, Qiao Zong, Jing Wang, Zuxun Lu, Xiaoxv Yin
Publikováno v:
International Journal of Infectious Diseases, Vol 104, Iss , Pp 641-648 (2021)
Objective: To assess the efficacy and safety of ribavirin and interferon-α (RBV/IFN-α) therapy in COVID-19 patients. Methods: A multicenter, retrospective cohort study of COVID-19 patients admitted to 4 hospitals in Hubei Province, China, from 31 D
Externí odkaz:
https://doaj.org/article/082d5e9f4e074697848bebf737153d26
Autor:
Gang Wang, Feng Ming Luo, Dan Liu, Jia Sheng Liu, Ye Wang, Hong Chen, Pan Wen Tian, Tao Fan, Li Tang, He Yu, Lan Wang, Mei Feng, Zhong Ni, Bo Wang, Zhi Fang Song, Xiao Ling Wu, Hong Jun Wang, Xiang Tong, Miao Xue, Xian Ying Lei, Bo Long, Chao Jia, Jun Xiao, Juan Shang, Nian Xiong, Jian Fei Luo, Zong An Liang, Wei Min Li, on behalf of the Sichuan & Wuhan Collaboration Research Group, and Sichuan Treatment Expert Group for COVID-19, China
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-15 (2021)
Abstract Background There is limited information on the difference in epidemiology, clinical characteristics and outcomes of the initial outbreak of the coronavirus disease (COVID-19) in Wuhan (the epicenter) and Sichuan (the peripheral area) in the
Externí odkaz:
https://doaj.org/article/46f5d23aed1b4d748acb3fe74731ea14
Autor:
Jingwen Li, Xi Long, Qing Zhang, Xi Fang, Huiling Luo, Fang Fang, Xuefei Lv, Dandan Zhang, Yu Sun, Na Li, Shaoping Hu, Jinghong Li, Nian Xiong, Zhicheng Lin
Publikováno v:
iScience, Vol 25, Iss 6, Pp 104415- (2022)
Summary: COVID-19 outbreaks have crushed our healthcare systems, which requires clinical guidance for the healthcare following the outbreaks. We conducted retrospective cohort studies with Pearson’s pattern-based analysis of clinical parameters of
Externí odkaz:
https://doaj.org/article/e9b8f01bb36d42b6b6f5da6328bb2ec0
Autor:
Chuan Li, Fengming Luo, Chengwu Liu, Nian Xiong, Zhihua Xu, Wei Zhang, Ming Yang, Ye Wang, Dan Liu, Chao Yu, Jia Zeng, Li Zhang, Duo Li, Yanbin Liu, Mei Feng, Ruoyang Liu, Jiandong Mei, Senyi Deng, Zhen Zeng, Yuanhong He, Haiyan Liu, Zhengyu Shi, Meng Duan, Deying Kang, Jiayu Liao, Weimin Li, Lunxu Liu
Publikováno v:
Annals of Medicine, Vol 53, Iss 1, Pp 391-401 (2021)
AbstractBackground There are few effective therapies for coronavirus disease 2019 (COVID-19) upon the outbreak of the pandemic. To compare the effectiveness of a novel genetically engineered recombinant super-compound interferon (rSIFN-co) with tradi
Externí odkaz:
https://doaj.org/article/1c8e5e4bc8854d9e90ac0409a97370b6